Fate Therapeutics Inc (FATE)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)

3535 GENERAL ATOMICS COURT SAN DIEGO, CA 92121

Fate Therapeutics, Inc provides biotechnology services. The company researches and develops therapies to repair and regenerate body tissues with the help of stem cells.

Data as of 2021-04-11 07:32:36 -0400
Market Cap6.804 Billion Shares Outstanding87.244 Million Avg 30-day Volume1.076 Million
P/E Ratio Dividend Yield EPS
Price/Sales Debt to Equity EBITDA
Price to Book Value0.0 Forward PE-41.99 Enterprise Value
Total Cash Current Debt Gross Profit
BETA1.58481 52-week High/Low121.16 / 25.6 Next Earnings Date2021-05-04 Price to Cash FLow (P/CF) -9999999.0
Data provided by IEX Cloud
View SEC Filings from FATE instead.
Q4 2020 All 13F Filers Prior Change Hedge Funds 1 Prior Change
In top 10: 12 8 50.0% 4 (0.24%) 5 (0.31%) -20.0%
Funds Holding: 245 211 16.11% 82 (4.93%) 74 (4.61%) 10.81%
13F shares: 86.677 Million 86.934 Million -0.3% 33.728 Million 33.684 Million 0.13%
% Ownership 99.3496 99.6447 -0.3% 38.6596 38.6094 0.13%
New Positions: 64 29 120.69% 22 15 46.67%
Increased Positions 70 87 -19.54% 19 28 -32.14%
Closed Positions 28 20 40.0% 14 13 7.69%
Reduced Positions 93 64 45.31% 35 23 52.17%
Total Calls 277.869 Thousand 267.408 Thousand 3.91% 103.24 Thousand 99.1 Thousand 4.18%
Total Puts 208.946 Thousand 180.669 Thousand 15.65% 120.141 Thousand 79.954 Thousand 50.26%
PUT/CALL Ratio 0.75 0.68 10.29% 1.16 0.81 43.21%
Heat Map Ranking 40
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Fate Therapeutics Inc YCharts
Yahoo! Finance finviz
SEC Web Site SEC DEF 14A Filings

WhaleWisdom Alpha

Our Other Reporting & Analysis

Funds Holding FATE (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
Click for Additional Filters
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding FATE BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

100 Thousand total shares from 26 transactions

Exercise Derivative Conversion (M)

75 Thousand total shares from 4 transactions

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

TAHL CINDY SEE REMARKS

  • Officer
 118,506 2021-04-01 7

CHU YU-WAYE SEE REMARKS

  • Officer
 68,075 2021-03-24 1

VALAMEHR BAHRAM CHIEF DEVELOPMENT OFFICER

  • Officer
 111,896 2021-03-15 5

SHOEMAKER DANIEL D CHIEF SCIENTIFIC OFFICER

  • Officer
 73,020 2021-03-08 5

WOLCHKO J SCOTT PRESIDENT AND CEO

  • Officer
  • Director
 393,793 2021-02-18 5

DULAC EDWARD J III CHIEF FINANCIAL OFFICER

  • Officer
 58,013 2021-01-20 3

REDMILE GROUP, LLC

GREEN JEREMY

  • Director
  • 10% Owner
 12,957,222 2021-01-08 2

COUGHLIN TIMOTHY

  • Director
 0 2020-05-01 1

RASTETTER WILLIAM H

  • Director
 0 2020-05-01 1

MENDLEIN JOHN

  • Director
 0 2020-05-01 1

EPSTEIN ROBERT S

  • Director
 0 2020-05-01 1

LEE MICHAEL STEWART

  • Director
 0 2020-05-01 1

JOOSS KARIN

  • Director
 0 2020-05-01 1

AGARWAL SHEFALI

  • Director
 0 2020-05-01 1

HERSHBERG ROBERT

  • Director
 0 2020-05-01 2

NASHAT AMIR

  • Director
 2,310,432 2019-07-31 0

ABBOT STEWART CHIEF DEVELOPMENT OFFICER

  • Officer
 64,917 2018-05-15 0

STORGARD CHRIS CHIEF MEDICAL OFFICER

  • Officer
 0 2018-01-16 0

ENYEDY MARK J

  • Director
 0 2017-05-02 0

FATE THERAPEUTICS INC CHIEF SCIENTIFIC OFFICER

  • Officer
 103,816 2016-01-08 0

WEYER CHRISTIAN SEE REMARKS

  • Officer
  • Director
 30,429 2015-04-13 0

MULTANI PRATIK S CHIEF MEDICAL OFFICER

  • Officer
 3,024 2015-01-05 0

FLYNN PETER D SEE REMARKS

  • Officer
 6,505 2015-01-05 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed		 Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

TAHL CINDY - Officer SEE REMARKS

2021-04-02 18:03:43 -0400 2021-04-01 M 28,149 d 0 direct yes

TAHL CINDY - Officer SEE REMARKS

2021-04-02 18:03:43 -0400 2021-04-01 S 4,835 $85.98 d 113,747 direct yes -4.2553 -10.3514 0.0 1 -10.3514 6

TAHL CINDY - Officer SEE REMARKS

2021-04-02 18:03:43 -0400 2021-04-01 S 4,556 $82.69 d 124,272 direct yes -4.2553 -10.3514 0.0 1 -10.3514 6

TAHL CINDY - Officer SEE REMARKS

2021-04-02 18:03:43 -0400 2021-04-01 M 1,851 $7.87 a 138,048 direct yes -4.2553 -10.3514 0.0 1 -10.3514 6

TAHL CINDY - Officer SEE REMARKS

2021-04-02 18:03:43 -0400 2021-04-01 S 400 $87.45 d 108,048 direct yes -4.2553 -10.3514 0.0 1 -10.3514 6

TAHL CINDY - Officer SEE REMARKS

2021-04-02 18:03:43 -0400 2021-04-01 S 2,200 $84.48 d 118,582 direct yes -4.2553 -10.3514 0.0 1 -10.3514 6

TAHL CINDY - Officer SEE REMARKS

2021-04-02 18:03:43 -0400 2021-04-01 S 8,220 $81.48 d 128,828 direct yes -4.2553 -10.3514 0.0 1 -10.3514 6

TAHL CINDY - Officer SEE REMARKS

2021-04-02 18:03:43 -0400 2021-04-01 M 28,149 $2.90 a 136,197 direct yes -4.2553 -10.3514 0.0 1 -10.3514 6

TAHL CINDY - Officer SEE REMARKS

2021-04-02 18:03:43 -0400 2021-04-01 M 1,851 d 10,458 direct yes

TAHL CINDY - Officer SEE REMARKS

2021-04-02 18:03:43 -0400 2021-04-01 S 5,299 $86.76 d 108,448 direct yes -4.2553 -10.3514 0.0 1 -10.3514 6

TAHL CINDY - Officer SEE REMARKS

2021-04-02 18:03:43 -0400 2021-04-01 S 3,490 $83.40 d 120,782 direct yes -4.2553 -10.3514 0.0 1 -10.3514 6

TAHL CINDY - Officer SEE REMARKS

2021-04-02 18:03:43 -0400 2021-04-01 S 1,000 $80.49 d 137,048 direct yes -4.2553 -10.3514 0.0 1 -10.3514 6

VALAMEHR BAHRAM - Officer CHIEF DEVELOPMENT OFFICER

2021-03-16 16:05:19 -0400 2021-03-15 S 1,018 $94.59 d 95,740 direct yes -6.3201 -10.668 0.1635 4 -10.668 6

VALAMEHR BAHRAM - Officer CHIEF DEVELOPMENT OFFICER

2021-03-16 16:05:19 -0400 2021-03-15 S 8,416 $91.94 d 108,367 direct yes -6.3201 -10.668 0.1635 4 -10.668 6

VALAMEHR BAHRAM - Officer CHIEF DEVELOPMENT OFFICER

2021-03-16 16:05:19 -0400 2021-03-15 S 3,205 $93.75 d 96,758 direct yes -6.3201 -10.668 0.1635 4 -10.668 6

VALAMEHR BAHRAM - Officer CHIEF DEVELOPMENT OFFICER

2021-03-16 16:05:19 -0400 2021-03-15 S 3,957 $90.89 d 116,783 direct yes -6.3201 -10.668 0.1635 4 -10.668 6

VALAMEHR BAHRAM - Officer CHIEF DEVELOPMENT OFFICER

2021-03-16 16:05:19 -0400 2021-03-15 M 25,000 d 16,156 direct yes

VALAMEHR BAHRAM - Officer CHIEF DEVELOPMENT OFFICER

2021-03-16 16:05:19 -0400 2021-03-15 S 8,404 $92.64 d 99,963 direct yes -6.3201 -10.668 0.1635 4 -10.668 6

VALAMEHR BAHRAM - Officer CHIEF DEVELOPMENT OFFICER

2021-03-16 16:05:19 -0400 2021-03-15 M 25,000 $2.90 d 120,740 direct yes -6.3201 -10.668 0.1635 4 -10.668 6

SHOEMAKER DANIEL D - Officer CHIEF SCIENTIFIC OFFICER

2021-03-09 16:02:06 -0500 2021-03-08 S 800 $86.70 d 73,020 direct yes 8.6923 2.1369 8.6923 2 -0.1336 5

SHOEMAKER DANIEL D - Officer CHIEF SCIENTIFIC OFFICER

2021-03-09 16:02:06 -0500 2021-03-08 S 2,480 $83.46 d 79,448 direct yes 8.6923 2.1369 8.6923 2 -0.1336 5

SHOEMAKER DANIEL D - Officer CHIEF SCIENTIFIC OFFICER

2021-03-09 16:02:06 -0500 2021-03-08 S 4,627 $79.58 d 90,095 direct yes 8.6923 2.1369 8.6923 2 -0.1336 5

SHOEMAKER DANIEL D - Officer CHIEF SCIENTIFIC OFFICER

2021-03-09 16:02:06 -0500 2021-03-08 S 2,900 $85.50 d 73,820 direct yes 8.6923 2.1369 8.6923 2 -0.1336 5

SHOEMAKER DANIEL D - Officer CHIEF SCIENTIFIC OFFICER

2021-03-09 16:02:06 -0500 2021-03-08 S 2,993 $81.60 d 81,928 direct yes 8.6923 2.1369 8.6923 2 -0.1336 5

SHOEMAKER DANIEL D - Officer CHIEF SCIENTIFIC OFFICER

2021-03-09 16:02:06 -0500 2021-03-08 S 3,298 $78.60 d 94,722 direct yes 8.6923 2.1369 8.6923 2 -0.1336 5

SHOEMAKER DANIEL D - Officer CHIEF SCIENTIFIC OFFICER

2021-03-09 16:02:06 -0500 2021-03-08 S 2,728 $84.20 d 76,720 direct yes 8.6923 2.1369 8.6923 2 -0.1336 5

SHOEMAKER DANIEL D - Officer CHIEF SCIENTIFIC OFFICER

2021-03-09 16:02:06 -0500 2021-03-08 S 5,174 $80.73 d 84,921 direct yes 8.6923 2.1369 8.6923 2 -0.1336 5

WOLCHKO J SCOTT - Director - Officer PRESIDENT AND CEO

2021-02-19 16:07:51 -0500 2021-02-18 M 20,000 $6.62 a 413,793 direct yes -5.4279 -4.3086 -20.6616 0.0 1 -28.5261 25

WOLCHKO J SCOTT - Director - Officer PRESIDENT AND CEO

2021-02-19 16:07:51 -0500 2021-02-18 S 5,547 $103.16 d 393,793 direct yes -5.4279 -4.3086 -20.6616 0.0 1 -28.5261 25

WOLCHKO J SCOTT - Director - Officer PRESIDENT AND CEO

2021-02-19 16:07:51 -0500 2021-02-18 S 1,848 $100.48 d 410,544 direct yes -5.4279 -4.3086 -20.6616 0.0 1 -28.5261 25

WOLCHKO J SCOTT - Director - Officer PRESIDENT AND CEO

2021-02-19 16:07:51 -0500 2021-02-18 S 8,602 $102.26 d 399,340 direct yes -5.4279 -4.3086 -20.6616 0.0 1 -28.5261 25

WOLCHKO J SCOTT - Director - Officer PRESIDENT AND CEO

2021-02-19 16:07:51 -0500 2021-02-18 S 1,401 $99.08 d 412,392 direct yes -5.4279 -4.3086 -20.6616 0.0 1 -28.5261 25

WOLCHKO J SCOTT - Director - Officer PRESIDENT AND CEO

2021-02-19 16:07:51 -0500 2021-02-18 M 20,000 d 14,846 direct yes

WOLCHKO J SCOTT - Director - Officer PRESIDENT AND CEO

2021-02-19 16:07:51 -0500 2021-02-18 S 2,602 $101.42 d 407,942 direct yes -5.4279 -4.3086 -20.6616 0.0 1 -28.5261 25

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
FATE THERAPEUTICS INC FATE 2021-04-14 22:15:03 UTC -0.1943 0.2543 700000
FATE THERAPEUTICS INC FATE 2021-04-14 21:45:03 UTC -0.1919 0.2519 700000
FATE THERAPEUTICS INC FATE 2021-04-14 21:15:03 UTC -0.1919 0.2519 700000
FATE THERAPEUTICS INC FATE 2021-04-14 20:45:03 UTC -0.1902 0.2502 700000
FATE THERAPEUTICS INC FATE 2021-04-14 20:15:04 UTC -0.1902 0.2502 700000
FATE THERAPEUTICS INC FATE 2021-04-14 19:45:03 UTC -0.1902 0.2502 700000
FATE THERAPEUTICS INC FATE 2021-04-14 19:15:03 UTC -0.1902 0.2502 700000
FATE THERAPEUTICS INC FATE 2021-04-14 18:45:02 UTC -0.1937 0.2537 700000
FATE THERAPEUTICS INC FATE 2021-04-14 18:15:03 UTC -0.1937 0.2537 700000
FATE THERAPEUTICS INC FATE 2021-04-14 17:45:03 UTC -0.1937 0.2537 700000
FATE THERAPEUTICS INC FATE 2021-04-14 17:15:03 UTC -0.1937 0.2537 700000
FATE THERAPEUTICS INC FATE 2021-04-14 16:45:03 UTC -0.1945 0.2545 700000
FATE THERAPEUTICS INC FATE 2021-04-14 16:15:03 UTC -0.1945 0.2545 700000
FATE THERAPEUTICS INC FATE 2021-04-14 15:45:03 UTC -0.1945 0.2545 700000
FATE THERAPEUTICS INC FATE 2021-04-14 15:15:03 UTC -0.1945 0.2545 700000
FATE THERAPEUTICS INC FATE 2021-04-14 14:45:02 UTC -0.19 0.25 700000
FATE THERAPEUTICS INC FATE 2021-04-14 14:15:03 UTC -0.19 0.25 700000
FATE THERAPEUTICS INC FATE 2021-04-14 13:45:03 UTC -0.19 0.25 700000
FATE THERAPEUTICS INC FATE 2021-04-14 13:15:03 UTC -0.19 0.25 700000
FATE THERAPEUTICS INC FATE 2021-04-14 12:45:03 UTC -0.19 0.25 700000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin
RUSSELL INVESTMENT FUNDS- U.S. Small Cap Equity Fund FATE -1109.0 shares, $-100841.37 2020-12-31 N-PORT
LoCorr Investment Trust- LoCorr Dynamic Equity Fund FATE -256.0 shares, $-23278.08 2020-12-31 N-PORT
Trust for Professional Managers- Convergence Market Neutral Fund FATE -1793.0 shares, $-65265.2 2020-08-31 N-PORT
FundVantage Trust- Gotham Hedged Plus Fund FATE -406.0 shares, $-36917.58 2020-12-31 N-PORT
FundVantage Trust- Gotham Defensive Long Fund FATE -75.0 shares, $-1665.75 2020-03-31 N-PORT
FundVantage Trust- Gotham Index Plus All-Cap Fund FATE -22.0 shares, $-488.62 2020-03-31 N-PORT
RUSSELL INVESTMENT CO- Sustainable Equity Fund FATE -726.0 shares, $-65797.38 2021-01-31 N-PORT
RUSSELL INVESTMENT CO- U.S. Dynamic Equity Fund FATE -972.0 shares, $-88092.36 2021-01-31 N-PORT

Elevate your investments